ATE365534T1 - Kosmetische hautpflegezusammensetzungen - Google Patents

Kosmetische hautpflegezusammensetzungen

Info

Publication number
ATE365534T1
ATE365534T1 AT03253154T AT03253154T ATE365534T1 AT E365534 T1 ATE365534 T1 AT E365534T1 AT 03253154 T AT03253154 T AT 03253154T AT 03253154 T AT03253154 T AT 03253154T AT E365534 T1 ATE365534 T1 AT E365534T1
Authority
AT
Austria
Prior art keywords
skin care
care compositions
cosmetic skin
cosmetic
compositions
Prior art date
Application number
AT03253154T
Other languages
English (en)
Inventor
Jan Marini
Original Assignee
Jan Marini Skin Res Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=29549302&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE365534(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Jan Marini Skin Res Inc filed Critical Jan Marini Skin Res Inc
Application granted granted Critical
Publication of ATE365534T1 publication Critical patent/ATE365534T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Dermatology (AREA)
  • Cosmetics (AREA)
AT03253154T 2002-06-03 2003-05-20 Kosmetische hautpflegezusammensetzungen ATE365534T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10/161,884 US6821524B2 (en) 2002-06-03 2002-06-03 Cosmetic skin care compositions

Publications (1)

Publication Number Publication Date
ATE365534T1 true ATE365534T1 (de) 2007-07-15

Family

ID=29549302

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03253154T ATE365534T1 (de) 2002-06-03 2003-05-20 Kosmetische hautpflegezusammensetzungen

Country Status (4)

Country Link
US (1) US6821524B2 (de)
EP (1) EP1369107B1 (de)
AT (1) ATE365534T1 (de)
DE (1) DE60314565T2 (de)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU766826B2 (en) * 1998-07-30 2003-10-23 Government of The United States of America, as represented by The Secretary Department of Health & Human Services, The National Institutes of Health, The Thymosin beta4 promotes wound repair
US20040170625A1 (en) * 1998-07-30 2004-09-02 Regenerx Biopharmaceuticals, Inc. Methods of treating Epidermolysis Bullosa and associated dermatological indications with thymosin beta 4, analogues, isoforms and other derivatives
US20070015698A1 (en) * 1998-07-30 2007-01-18 United States Of America As Represented By The Secretary Of Health Treatment of skin, and wound repair, with thymosin beta 4
US20040067227A1 (en) * 2001-11-02 2004-04-08 Goldstein Allan L. Inhibition or reversal of skin aging by actin-sequestering peptides
US7736636B2 (en) * 2003-02-12 2010-06-15 Shaker Mousa Method for treating occlusive vascular diseases & wound healing
KR100716119B1 (ko) * 2005-10-24 2007-05-10 (주)케어젠 모발 성장을 촉진하는 펩티드 및 이를 이용한 화장품
CN101374860A (zh) 2005-12-23 2009-02-25 技术转让合伙人公司 用作神经递质分泌抑制剂和肌肉松弛诱导物的合成肽
TWI415628B (zh) 2006-02-28 2013-11-21 Avon Prod Inc 包含具有非天然胺基酸之胜肽之組合物及其使用方法
EP1886676A1 (de) * 2006-08-09 2008-02-13 Polichem S.A. Zusammensetzungen mit verstärkter elastizierender Aktivität
EP2139447A2 (de) * 2007-03-20 2010-01-06 Harold Brem Gm-csf-kosmezeutikazusammensetzungen und verfahren zu ihrer verwendung
US20080234194A1 (en) * 2007-03-20 2008-09-25 Harold Brem Growth factor mediated cosmeceuticals and use thereof to enhance skin quality
BRPI0913983A2 (pt) * 2008-06-30 2015-10-20 Orf Liftaekni Hf composição cosmética e/ou terapêutica, e, método para fabricar um produto para cuidado da pele tópico
US8580742B2 (en) 2010-03-05 2013-11-12 N.V. Perricone Llc Topical glutathione formulations for menopausal skin
US8609604B2 (en) 2009-12-28 2013-12-17 N.V. Perricone Llc Methods of improving the appearance of aging skin
US20110160144A1 (en) * 2009-12-28 2011-06-30 Perricone Nicholas V Topical Acyl Glutathione Formulations
US8633178B2 (en) 2011-11-23 2014-01-21 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US8632827B2 (en) * 2011-12-13 2014-01-21 Avon Products, Inc Modulation of thymosin beta-4 in skin
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US20140066837A1 (en) 2012-07-26 2014-03-06 Ronald L. Moy Skin care compositions and methods
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9808654B2 (en) 2013-02-11 2017-11-07 Jan Marini Skin Research Post procedure skin care gel and methods of use thereof
EP3145489A1 (de) 2014-05-22 2017-03-29 TherapeuticsMD, Inc. Natürliche kombinierte hormonersatzformulierungen und therapien
US9572767B2 (en) 2015-05-20 2017-02-21 Jan Marini Skin Research Luminate hand cream
US10034825B2 (en) 2015-07-01 2018-07-31 Jan Marini Skin Research Luminate eye gel
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
US9949913B2 (en) 2016-03-14 2018-04-24 Jan Marini Skin Research Luminate face lotion
WO2017173044A1 (en) 2016-04-01 2017-10-05 Therapeuticsmd Inc. Steroid hormone compositions in medium chain oils
WO2017173071A1 (en) 2016-04-01 2017-10-05 Therapeuticsmd, Inc. Steroid hormone pharmaceutical composition
US10596090B2 (en) 2016-05-27 2020-03-24 Jan Marini Skin Research Cosmetic formulation to reduce facial flushing
KR102340750B1 (ko) * 2017-03-03 2021-12-21 에이치엘비테라퓨틱스 주식회사 티모신 베타 4를 유효성분으로 포함하는 안정화된 외용 제제
US10610479B2 (en) 2017-08-07 2020-04-07 Jan Marini Skin Research HYLA3D hyaluronic acid activating lip complex
AU2018313859B2 (en) * 2017-08-08 2024-08-01 Tetrous, Inc. Therapeutic gas infused cosmetic and methods of infusion
US10179103B1 (en) 2018-05-16 2019-01-15 Jan Marini Skin Research Anti-cellulite cream
US11633405B2 (en) 2020-02-07 2023-04-25 Therapeuticsmd, Inc. Steroid hormone pharmaceutical formulations

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4297276A (en) 1979-03-23 1981-10-27 Hoffman-La Roche Inc. Thymosin beta 3 and beta 4
AU5001793A (en) * 1992-08-12 1994-03-15 Bays-Brown Dermatologics, Inc. Method of decreasing cutaneous senescence
US20020049422A1 (en) * 1994-03-31 2002-04-25 Brewitt Barbara A. Homeopathic preparations
JP3144624B2 (ja) * 1995-06-02 2001-03-12 杏林製薬株式会社 Ｎ−ベンジルジオキソチアゾリジルベンズアミド誘導体及びその製造法
GB9600464D0 (en) * 1996-01-09 1996-03-13 Smithkline Beecham Plc Novel method
US20030153541A1 (en) * 1997-10-31 2003-08-14 Robert Dudley Novel anticholesterol compositions and method for using same
US6030948A (en) * 1997-12-19 2000-02-29 Mann; Morris A. Hair regeneration compositions for treatment of alopecia and methods of application related thereto
GB9806632D0 (en) * 1998-03-28 1998-05-27 Stevenson Robert Peptide factor
CA2230389A1 (en) * 1998-04-28 1999-10-28 Murray N. Waldman Formulations containing melatonin to be topically applied for the purpose of protecting the skin from oxidative damage
AU766826B2 (en) * 1998-07-30 2003-10-23 Government of The United States of America, as represented by The Secretary Department of Health & Human Services, The National Institutes of Health, The Thymosin beta4 promotes wound repair
PT1335743E (pt) * 2000-11-02 2010-03-29 Regenerx Biopharmaceuticals Inibição ou reversão do envelhecimento da pele por meio de péptidos sequestrando actina
US6328987B1 (en) 2000-11-03 2001-12-11 Jan Marini Skin Research, Inc. Cosmetic skin care compositions containing alpha interferon

Also Published As

Publication number Publication date
EP1369107A1 (de) 2003-12-10
DE60314565T2 (de) 2008-03-06
US6821524B2 (en) 2004-11-23
EP1369107B1 (de) 2007-06-27
US20030228266A1 (en) 2003-12-11
DE60314565D1 (de) 2007-08-09

Similar Documents

Publication Publication Date Title
ATE365534T1 (de) Kosmetische hautpflegezusammensetzungen
DE60110342D1 (de) Alpha-Interferon enthaltende Hautpflegemittel
ATE214590T1 (de) Körperpflegezusammensetzungen
MA22240A1 (fr) Compositions de soin de la peau
DE69916329D1 (de) Kosmetische formulierung
DE60237221D1 (de) Kosmetische und dermopharmazeutische zusammensetzungen für akneanfällige haut
DE60025147D1 (de) Kosmetische Zusammensetzung und Verwendungen
CY1108610T1 (el) Πεπτιδια της il-2 και παραγωγα αυτων και χρηση αυτων ως θεραπευτικοι παραγοντες
ATE355269T1 (de) Phenylalaninderivate
CY1107116T1 (el) Νεες κυκλοεξυλ σουλφονες
DE60307234D1 (de) Sonnenschutzzusammensetzungen sowie dihydropyridine und dihydropyrane
ID26999A (id) Komposisi perawatan kulit
FI972387A0 (fi) Iholle levitettäviä parasitisidikoostumuksia
GB0201743D0 (en) Cosmetic or personal care composition
DE60220258D1 (de) Derivate von quinolyl-propyl-piperidine, deren herstellung und die sie enthaltenden zusamensetzungen
DE69400318D1 (de) Silikon enthaltende Hautpflegezusammensetzungen
DE60108563D1 (de) Kosmetische Zusammensetzung für das Haar
DE60304645D1 (de) Hautpflegemittel enthaltend Octylmethoxycinnamat
ITMI20011022A0 (it) Composizioni farmaceutiche e cosmetiche contro l'invecchiamento cutaneo
ATE88699T1 (de) Oxidierte diphenylheteroalkane, ihre herstellung und verwendung.
DE60037014D1 (de) Kosmetische zusammensetzungen enthaltend polysaccharid-sterol-derivate
DE10195737T1 (de) Hautgummiermittel und kosmetische Formulierungen
DE60031477D1 (de) Kosmetische Zusammensetzung zum abreiben der Haut
ATE521331T1 (de) Verwendung von bis-resorcinyltriazinderivaten in kosmetischen oder dermatologischen zubereitungen
AU2003288971A1 (en) Compositions for darkening the skin and/or hair

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties